The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The Advent of Generative Chemistry
Open accessAbstract
Generative adversarial networks (GANs), first published in 2014, are among the most important concepts in modern artificial intelligence (AI). Bridging deep learning and game theory, GANs are used to generate or “imagine” new objects with desired properties. Since 2016, multiple GANs with reinforcement learning (RL) have been successfully applied in pharmacology for de novo molecular design. Those techniques aim at a more efficient use of the data and a better exploration of the chemical space. We review recent advances for the generation of novel molecules with desired properties with a focus on the applications of GANs, RL, and related techniques. We also discuss the current limitations and challenges in the new growing field of generative chemistry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The development of ultra-large chemical libraries (94) and generative chemistry methods, particularly those based on Generative Adversarial Networks (GANs), have significantly expanded the possibilities for hit generation and drug discovery.”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochreiter, S., & Schmidhuber, J. (1997) · Neural Computation · doi:10.1162/neco.1997.9.8.1735 · Cited by 102,318
Auto-Encoding Variational Bayes
Kingma, D. P., & Welling, M. (2013) · arXiv · doi:10.48550/arxiv.1312.6114 · Cited by 20,067
A Brief Survey of Deep Reinforcement Learning
Arulkumaran, K., Deisenroth, M. P., Brundage, M., & Bharath, A. A. (2017) · arXiv · doi:10.48550/arxiv.1708.05866 · Cited by 4,733
Deep Reinforcement Learning: A Brief Survey
Arulkumaran, K., Deisenroth, M. P., Brundage, M., & Bharath, A. A. (2017) · IEEE Signal Processing Magazine · doi:10.1109/msp.2017.2743240 · Cited by 4,733
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Generative Adversarial Networks
Drori, I. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108891530.013 · Cited by 2,557
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Mureşan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,397
Inverse molecular design using machine learning: Generative models for matter engineering
Sánchez-Lengeling, B., & Aspuru‐Guzik, A. (2018) · Science · doi:10.1126/science.aat2663 · Cited by 2,177
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
NIPS 2016 Tutorial: Generative Adversarial NetworksPreprint
Goodfellow, I. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1701.00160 · Cited by 2,048
Research works printed but not linked: 1
- Maziarka, Ł.; et al. Mol-CycleGAN - a generative model for molecular optimization. arXiv (Machine Learning), February 6, 2019, 1902.02119, ver. 1. https://arxiv.org/abs/1902.02119. · arXiv
Cited by
Sorted by citations
Computational approaches streamlining drug discovery
Sadybekov, A., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,424
Combining Machine Learning and Computational Chemistry for Predictive Insights Into Chemical Systems
Keith, J. A., Vassilev-Galindo, V., Cheng, B., Chmiela, S., Gastegger, M., Müller, K.-R., & Tkatchenko, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00107 · Cited by 849
Artificial intelligence in drug development
Zhang, K., Yang, X., Wang, Y., Yu, Y., Huang, N., Li, G. L., Li, X., Wu, J. C., & Yang, S. (2025) · Nature Medicine · doi:10.1038/s41591-024-03434-4 · Cited by 585
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Jackson, I., Ivanov, D., Dolgui, A. B., & Namdar, J. (2024) · International Journal of Production Research · doi:10.1080/00207543.2024.2309309 · Cited by 567
Metadata
- Authors
- Vanhaelen, Q., Lin, Y.-C., & Zhavoronkov, A.
- Affiliations
- Insilico Medicine Hong Kong Ltd , Pak Shek Kok , ,
- Corresponding author
- Vanhaelen, Quentin
- Venue
- ACS Medicinal Chemistry Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-07-14
- Volume
- 11
- Issue
- 8
- Pages
- 1496-1505
- ISSN
- 1948-5875 (ISSN-L)
- PMC
- PMC7429972
- OpenAlex
- W3043461363
- Cited by
- 151
- References
- 76
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 32 · 2023: 26 · 2022: 16 · 2021: 30 · 2020: 2
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- ACS Medicinal Chemistry Letters (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Generative Adversarial Networks and Image Synthesis
- Keywords
- generative chemistry, generative adversarial networks, reinforcement learning, de novo molecular design, drug discovery, chemical space exploration, molecular property prediction, generative models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
